Science Committee

Our Science Committee is responsible for the oversight, development, review, funding and management of a portfolio of basic and translational cancer research Programme and Project Awards.

The Science Committee meets twice a year, in April and October.

Research areas

The Science Committee has a broad remit spanning basic and translational cancer research, including fundamental biology, genetics and immunology, biomarker discovery and preclinical studies, and research into imaging and radiotherapy. The committee also supports researchers in fields such as engineering and physical sciences to apply their work to cancer.

Funding schemes

Programme Awards

Science Committee Programme Awards provide long-term support for broad, multidisciplinary research where the aim is to answer an interrelated set of questions. Applications for Programme Awards will be accepted in any of the following research areas:

  • Basic biological research relating to cancer
  • Preclinical studies that will generate biological data to underpin therapeutic development
  • Biomarker research
  • Imaging research
  • Radiotherapy research
  • The application of engineering and physical sciences to cancer

Programme Foundation Awards

Programme Foundation Awards allow excellent mid-career researchers to develop their independent research group. On completion of a Programme Foundation Award we expect researchers to be in a competitive position to apply for a Science Committee Programme Award. Applications will be accepted within the same scientific remit as Programme Awards.

Cancer Immunology Project Awards

Cancer Immunology Project Awards seek to catalyse research and build the UK's research base in cancer immunology, by funding immunologists in non-cancer fields.

Multidisciplinary Project Awards

The Multidisciplinary Project Award supports collaborations between clinical and non-clinical cancer researchers, and scientists from engineering/physical science disciplines, where the aim is to generate creative research ideas and explore their applicability in cancer research.

How proposals are judged

The Committee meets twice a year in April and October, and assesses all applications on the basis of their scientific and strategic importance, whilst also studying expert peer review collated for each grant. Applications are judged on the basis of scientific excellence, innovation and relevance to cancer research.

Professor of biochemistry - Gerard Evan

Gerard is an established independent researcher in basic and translational research who is funded by our Science Committee.

Committee and panel members

Chair of the Science Committee

Professor Gerard Evan – University of Cambridge

Vice Chair of the Science Committee

Professor Rosalind Eeles – The Institute of Cancer Research

Members of the Science Committee

Professor Mariann Bienz – MRC Laboratory of Molecular Biology

Professor Kevin Brindle – University of Cambridge

Professor Tim Elliott – University of Southampton

Professor Jane Endicott – Newcastle University

Professor Tariq Enver – University College London

Professor Awen Gallimore – Cardiff University

Professor Duncan Graham – University of Strathclyde

Professor Daniel Hochhauser – University College London

Professor Kairbaan Hodivala-Dilke – Queen Mary, University of London

Professor Tim Illidge – The University of Manchester

Professor Clare Isacke – The Institute of Cancer Research, London

Professor Josef Jiricny – University of Zurich

Professor Claus Jorgensen – Cancer Research UK Manchester Institute

Dr Jan Korbel – EMBL, Heidelberg

Professor Dr Rob Pieters – Prinses Máxima Centrum, 

Professor Steven Pollard – The University of Edinburgh

Professor Francisco Real – Spanish National Cancer Research Centre

Dr Erik Sahai – The Francis Crick Institute

Professor Charles Swanton (CRUK Chief Clinician) – The Francis Crick Institute & University College London

Professor Ian Tomlinson – University of Oxford

Sir Richard Treisman – The Francis Crick Institute

Professor Karen Vousden (CRUK Chief Scientist) – The Francis Crick Institute

Chair of the Cancer Immunology Review Panel

Professor Tim Elliott – University of Southampton

Vice Chair of the Cancer Immunology Review Panel

Professor Awen Gallimore – Cardiff University

Members of the Cancer Immunology Review Panel

Professor Vincenzo Cerundolo – University of Oxford

Professor George Kassiotis – The Francis Crick Institute

Professor Paul Martin – University of Bristol

Professor Hans Stauss – University College London

Professor Paresh Vyas – Weatherall Institute for Molecular Medicine

Chair of the Multidisciplinary Review Panel

Professor Kevin Brindle — University of Cambridge

Vice Chair of the Science Committee

Professor Duncan Graham — University of Strathclyde

Members of the Multidisciplinary Review Panel

Dr Sarah Bohndiek — University of Cambridge

Professor Steven Clifford — University of Newcastle

Dr Matthew Fuchter — Imperial College London

Professor Vicky Goh — King's College London

Professor Trevor Graham — Queen Mary University of London

Dr Claus Jorgensen — CRUK Manchester Institute

Professor Uwe Oelfke — The Institute of Cancer Research, London

Professor Erik Sahai — The Francis Crick Institute

Professor Julia Schnabel, King's College London

Professor Ben Simons — University of Cambridge

Dr Marco Gerlinger — The Institute of Cancer Research, London

 

Contact for this committee

Dr Matt Kaiser

Head of Discovery Research

science.committee@cancer.org.uk

More opportunities for discovery researchers

Discovery Research

We support a broad portfolio of discovery research, including basic biology, genetics and immunology, biomarker discovery and preclinical studies, and engineering and physical sciences applied to cancer. We have a variety of grant funding and other opportunities to accelerate your research.